Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Microbiol Resour Announc ; 9(35)2020 Aug 27.
Artículo en Inglés | MEDLINE | ID: mdl-32855259

RESUMEN

Here, we report four coding-complete severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome sequences from Stockholm, Sweden, sampled in late April 2020. A rare variant at bp 23463 of the SARS-CoV-2 genome was found, which corresponds to the S1 subunit of the spike protein, changing an arginine (R) residue to histidine (H).

2.
Nat Commun ; 10(1): 4703, 2019 10 16.
Artículo en Inglés | MEDLINE | ID: mdl-31619666

RESUMEN

Despite recent advances in understanding microbial diversity in skin homeostasis, the relevance of microbial dysbiosis in inflammatory disease is poorly understood. Here we perform a comparative analysis of skin microbial communities coupled to global patterns of cutaneous gene expression in patients with atopic dermatitis or psoriasis. The skin microbiota is analysed by 16S amplicon or whole genome sequencing and the skin transcriptome by microarrays, followed by integration of the data layers. We find that atopic dermatitis and psoriasis can be classified by distinct microbes, which differ from healthy volunteers microbiome composition. Atopic dermatitis is dominated by a single microbe (Staphylococcus aureus), and associated with a disease relevant host transcriptomic signature enriched for skin barrier function, tryptophan metabolism and immune activation. In contrast, psoriasis is characterized by co-occurring communities of microbes with weak associations with disease related gene expression. Our work provides a basis for biomarker discovery and targeted therapies in skin dysbiosis.


Asunto(s)
Dermatitis Atópica/genética , Interacciones Microbiota-Huesped/genética , Microbiota/genética , Psoriasis/genética , Piel/metabolismo , Piel/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Dermatitis Atópica/microbiología , Disbiosis/genética , Femenino , Expresión Génica , Perfilación de la Expresión Génica , Humanos , Masculino , Persona de Mediana Edad , Psoriasis/microbiología , ARN Ribosómico 16S , Adulto Joven
3.
Artículo en Inglés | MEDLINE | ID: mdl-30701077

RESUMEN

The gut microbiota has been linked to various neurological disorders via the gut-brain axis. Diet influences the composition of the gut microbiota. The ketogenic diet (KD) is a high-fat, adequate-protein, low-carbohydrate diet established for treatment of therapy-resistant epilepsy in children. Its efficacy in reducing seizures has been confirmed, but the mechanisms remain elusive. The diet has also shown positive effects in a wide range of other diseases, including Alzheimer's, depression, autism, cancer, and type 2 diabetes. We collected fecal samples from 12 children with therapy-resistant epilepsy before starting KD and after 3 months on the diet. Parents did not start KD and served as diet controls. Applying shotgun metagenomic DNA sequencing, both taxonomic and functional profiles were established. Here we report that alpha diversity is not changed significantly during the diet, but differences in both taxonomic and functional composition are detected. Relative abundance of bifidobacteria as well as E. rectale and Dialister is significantly diminished during the intervention. An increase in relative abundance of E. coli is observed on KD. Functional analysis revealed changes in 29 SEED subsystems including the reduction of seven pathways involved in carbohydrate metabolism. Decomposition of these shifts indicates that bifidobacteria and Escherichia are important contributors to the observed functional shifts. As relative abundance of health-promoting, fiber-consuming bacteria becomes less abundant during KD, we raise concern about the effects of the diet on the gut microbiota and overall health. Further studies need to investigate whether these changes are necessary for the therapeutic effect of KD.


Asunto(s)
Bacterias/clasificación , Dieta Cetogénica , Epilepsia/terapia , Microbioma Gastrointestinal/efectos de los fármacos , Microbiota/efectos de los fármacos , Adolescente , Bacterias/genética , Niño , Preescolar , Heces/microbiología , Femenino , Humanos , Lactante , Masculino , Metagenómica
4.
PLoS One ; 7(2): e30875, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22355331

RESUMEN

The human respiratory tract is heavily exposed to microorganisms. Viral respiratory tract pathogens, like RSV, influenza and rhinoviruses cause major morbidity and mortality from respiratory tract disease. Furthermore, as viruses have limited means of transmission, viruses that cause pathogenicity in other tissues may be transmitted through the respiratory tract. It is therefore important to chart the human virome in this compartment. We have studied nasopharyngeal aspirate samples submitted to the Karolinska University Laboratory, Stockholm, Sweden from March 2004 to May 2005 for diagnosis of respiratory tract infections. We have used a metagenomic sequencing strategy to characterize viruses, as this provides the most unbiased view of the samples. Virus enrichment followed by 454 sequencing resulted in totally 703,790 reads and 110,931 of these were found to be of viral origin by using an automated classification pipeline. The snapshot of the respiratory tract virome of these 210 patients revealed 39 species and many more strains of viruses. Most of the viral sequences were classified into one of three major families; Paramyxoviridae, Picornaviridae or Orthomyxoviridae. The study also identified one novel type of Rhinovirus C, and identified a number of previously undescribed viral genetic fragments of unknown origin.


Asunto(s)
Gripe Humana/genética , Metagenoma/genética , Metagenómica , Infecciones por Paramyxoviridae/genética , Infecciones por Picornaviridae/genética , Infecciones del Sistema Respiratorio/genética , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Humanos , Virus de la Influenza A/genética , Virus de la Influenza A/aislamiento & purificación , Gripe Humana/diagnóstico , Gripe Humana/virología , Persona de Mediana Edad , Nasofaringe/virología , Paramyxoviridae/genética , Paramyxoviridae/aislamiento & purificación , Infecciones por Paramyxoviridae/diagnóstico , Infecciones por Paramyxoviridae/virología , Filogenia , Picornaviridae/genética , Picornaviridae/aislamiento & purificación , Infecciones por Picornaviridae/diagnóstico , Infecciones por Picornaviridae/virología , Infecciones del Sistema Respiratorio/diagnóstico , Infecciones del Sistema Respiratorio/virología , Adulto Joven
5.
J Infect Dis ; 200(9): 1456-64, 2009 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-19807279

RESUMEN

Plasmodium falciparum response mechanisms to the major artemisinin-based combination therapies (ACTs) are largely unknown. Multidrug-resistance protein (MRP)-like adenosine triphosphate (ATP)-binding cassette transporters are known to be related to multidrug resistance in many organisms. Therefore, we hypothesized that sequence variation in pfmrp1 can contribute to decreased parasite sensitivity to ACT. Through sequencing of the pfmrp1 open reading frame for 103 geographically diverse P. falciparum infections, we identified 27 single-nucleotide polymorphisms (SNPs), of which 21 were nonsynonymous and 6 synonymous. Analyses of clinical efficacy trials with artesunate-amodiaquine and artemether-lumefantrine detected a specific selection of the globally prevalent I876V SNP in recurrent infections after artemether-lumefantrine treatment. Additional in silico studies suggested an influence of variation in amino acid 876 on the ATP hydrolysis cycle of pfMRP1 with potential impact on protein functionality. Our data suggest for the first time, to our knowledge, the involvement of pfMRP1 in P. falciparum in vivo response to ACT.


Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/genética , Antimaláricos/uso terapéutico , Artemisininas/uso terapéutico , Resistencia a Medicamentos/genética , Plasmodium falciparum/efectos de los fármacos , Plasmodium falciparum/genética , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/química , África , Animales , Ensayos Clínicos como Asunto , Quimioterapia Combinada , Humanos , Sistemas de Lectura Abierta/genética , Polimorfismo de Nucleótido Simple/genética , Selección Genética , Suecia , Viaje
7.
Proteomics ; 8(13): 2735-49, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18546153

RESUMEN

The completion of the genome sequence of Trypanosoma cruzi has been followed by several studies of protein expression, with the long-term aim to obtain a complete picture of the parasite proteome. We report a proteomic analysis of an organellar cell fraction from T. cruzi CL Brener epimastigotes. A total of 396 proteins were identified by LC-MS/MS. Of these, 138 were annotated as hypothetical in the genome databases and the rest could be assigned to several metabolic and biosynthetic pathways, transport, and structural functions. Comparative analysis with a whole cell proteome study resulted in the validation of the expression of 173 additional proteins. Of these, 38 proteins previously reported in other stages were not found in the only large-scale study of the total epimastigote stage proteome. A selected set of identified proteins was analyzed further to investigate gene copy number, sequence variation, transmembrane domains, and targeting signals. The genes were cloned and the proteins expressed with a c-myc epitope tag in T. cruzi epimastigotes. Immunofluorescence microscopy revealed the localization of these proteins in different cellular compartments such as ER, acidocalcisome, mitochondrion, and putative cytoplasmic transport or delivery vesicles. The results demonstrate that the use of enriched subcellular fractions allows the detection of T. cruzi proteins that are undetected by whole cell proteomic methods.


Asunto(s)
Orgánulos/metabolismo , Proteínas/análisis , Proteómica/métodos , Trypanosoma cruzi/citología , Trypanosoma cruzi/metabolismo , Animales , Biología Computacional/métodos , Estadios del Ciclo de Vida , Modelos Biológicos , Proteínas/química , Proteínas/clasificación , Proteínas/metabolismo , Reproducibilidad de los Resultados , Trypanosoma cruzi/genética , Trypanosoma cruzi/crecimiento & desarrollo
8.
Science ; 309(5733): 409-15, 2005 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-16020725

RESUMEN

Whole-genome sequencing of the protozoan pathogen Trypanosoma cruzi revealed that the diploid genome contains a predicted 22,570 proteins encoded by genes, of which 12,570 represent allelic pairs. Over 50% of the genome consists of repeated sequences, such as retrotransposons and genes for large families of surface molecules, which include trans-sialidases, mucins, gp63s, and a large novel family (>1300 copies) of mucin-associated surface protein (MASP) genes. Analyses of the T. cruzi, T. brucei, and Leishmania major (Tritryp) genomes imply differences from other eukaryotes in DNA repair and initiation of replication and reflect their unusual mitochondrial DNA. Although the Tritryp lack several classes of signaling molecules, their kinomes contain a large and diverse set of protein kinases and phosphatases; their size and diversity imply previously unknown interactions and regulatory processes, which may be targets for intervention.


Asunto(s)
Genoma de Protozoos , Proteínas Protozoarias/genética , Análisis de Secuencia de ADN , Trypanosoma cruzi/genética , Animales , Enfermedad de Chagas/tratamiento farmacológico , Enfermedad de Chagas/parasitología , Reparación del ADN , Replicación del ADN , ADN Mitocondrial/genética , ADN Protozoario/genética , Genes Protozoarios , Humanos , Meiosis , Proteínas de la Membrana/química , Proteínas de la Membrana/genética , Proteínas de la Membrana/fisiología , Familia de Multigenes , Proteínas Protozoarias/química , Proteínas Protozoarias/fisiología , Recombinación Genética , Secuencias Repetitivas de Ácidos Nucleicos , Retroelementos , Transducción de Señal , Telómero/genética , Tripanocidas/farmacología , Tripanocidas/uso terapéutico , Trypanosoma cruzi/química , Trypanosoma cruzi/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...